Bachelot T, Cottu P, Chabaud S, Dalenc F, et al. Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer. J Clin Oncol 2022 May 23:JCO2102179. doi: 10.1200/JCO.21.02179.
PMID: 35605174